India ready to save humanity with two vaccines, says Modi

Our nation is self-reliant today, he remarks in Pravasi Bharatiya Divas address

Updated - January 09, 2021 10:04 pm IST

Published - January 09, 2021 12:08 pm IST - New Delhi

Prime Minister Narendra Modi. File

Prime Minister Narendra Modi. File

Amid the global clamour for coronavirus vaccines, Prime Minister Narendra Modi on Saturday said India was ready to save humanity by providing doses of the two Indian-manufactured vaccines that have been cleared for emergency use, Covishield and Covaxin, to the rest of the world.

“India used to import PPE kits, masks, ventilators and testing kits from outside but today our nation is self-reliant. Today, India is ready to save humanity with two ‘Made in India’ coronavirus vaccines,” Mr. Modi told the Indian diaspora, inaugurating the Pravasi Bharatiya Divas over videoconference, in which Suriname President Chandrikapersad Santokhi was Chief Guest.

Mr. Modi lauded Indian-origin citizens around the world, who he said were at the forefront of the fight against the coronavirus pandemic. He also said that Indian-origin leaders were trusted in their countries for social and political leadership. In his speech, he also praised India’s “vibrant and strong democracy”, and its role as a leading pharmaceutical and vaccine producer.

“Being the pharmacy of the world, India has supplied important medicines to all those in need in the world in the past and is also doing so now. The world is not only waiting for Indian vaccines but also watching how India runs the world biggest vaccination programme,” Mr. Modi said, referring to India’s plans to roll out a vaccination programme that the government says will begin by mid-January and inoculate 300 million people by July 2021.


The Drugs Controller General of India on January 3 approved two vaccines — Covishield, the vaccine developed by U.K.’s AstraZeneca and Oxford University, being manufactured by Serum Institute of India (SII), and Covaxin, manufactured by Bharat Biotech.

However, the government has not yet announced any purchase contract with either of the two, nor is it clear how soon the production capacity for both internal consumption and export orders will be reached. Last week, SII said it had stockpiled 50 million doses, while Bharat Biotech said it has readied 10 million doses.

Global interest

Mr. Modi’s statement comes even as various countries have expressed their interest in procuring vaccines from Indian companies.

External Affairs Minister S. Jaishankar announced that Sri Lanka would be given priority for the vaccines after a meeting with Sri Lankan President Gotabaya Rajapaksa, who had asked India for supplies.

Myanmar leader Aung San Suu Kyi said in a New Year’s address to her nation that the contract for Indian vaccines had been signed, and her government was ready to import them once India issued the necessary clearances for their export.

Next week, Nepal Foreign Minister Pradeep Gyawali is expected to discuss procurement of the Indian vaccines and possibly sign a contract for them. Meanwhile, Brazilian President Jair Bolsonaro has written a letter to Mr. Modi, asking India to expedite the export of two million vaccine doses that had been ordered from SII through a contract with Astra Zeneca.

“There is understandably interest in many countries to access vaccines from India,” said MEA spokesperson Anurag Srivastava on Friday. “India sees international cooperation in this field, particularly with neighbours, as its duty. In our neighbourhood, we have already provided medicines and other essentials and training assistance for experts. As we roll out vaccines, the Prime Minister’s announcement that our vaccine capacity will be used for the benefit of all humanity in fighting the crisis needs to be noted,” he added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.